Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H ( (HK:2291) ) is now available.
LEPU ScienTech Medical Technology announced a significant increase in its financial performance for the first half of 2025, with a 32.4% rise in revenue and a 29.8% increase in net profit attributable to shareholders. Despite these gains, the company decided not to distribute an interim dividend. The company’s continued focus on innovation and expansion in the interventional medical devices sector, with numerous products in various stages of development, positions it strongly within the industry.
More about LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is a prominent player in the interventional medical devices industry in China, focusing on the research, development, manufacture, and commercialization of heart disease interventional devices. With over 20 years of experience, the company has been advancing in degradable medical devices and exploring new areas such as heart valves and cardiac mechanical circulatory support.
Average Trading Volume: 962,272
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$9.02B
For an in-depth examination of 2291 stock, go to TipRanks’ Overview page.